With more than 5,000 CAR-T infusions registered in the EBMT Registry, EBMT and EHA are proud to announce the third call for research proposals within the Scientific Excellence Work Package of the GoCART Coalition.
The aim of the call is to promote the use of existing Registry data and other sources of real world data and to strengthen collaborations across stakeholders in the field of CAR T-cell therapies. Proposals for retrospective studies must be presented by collaborations of stakeholders involved in the GoCART Coalition.
Would you like to contribute to the advancement of the CAR T-cell therapy field and do you have a good study proposal? Please submit your proposal using the form and send it to GoCART@ebmt.org. The deadline for submission is Friday 8 September 2023.
Proposals that are received before the submission deadline will be evaluated by a selection committee with EBMT and EHA leadership and patient representative against four criteria: scientific impact, novelty, collaboration across stakeholders and feasibility of the proposal. The five winning proposals will be announced on Friday 15 December 2023 .
EBMT will be economically supporting the selected studies that are proposed by noncommercial partners by providing the required resources to conduct the study. The EBMT business unit will draw up a budget for the conduct of any selected proposal that includes a pharmaceutical company.
Looking forward to an exciting scientific wave of proposals and discussions.
On behalf of EBMT,
Prof Dr Anna Sureda, President of the EBMT
On behalf of EHA,
Prof Antonio Almeida, President of EHA